Seventy-five percent of ophthalmic interventions investigated in a major study have shown evidence of improving quality of life for patients with eye disease, with cataract surgery and anti-VEGF therapy singled out as some of the most important procedures. Read more
CooperVision and Essilor announce JV for acquisition of myopia spectacle lens
The parent companies of CooperVision and Essilor have announced a new joint venture to acquire a spectacle lens approved for myopia control in several countries. Read more
Study reveals age optometrists are most comfortable fitting CLs in paediatric myopes
A new global myopia survey that involved Australian participants has revealed optometrists are comfortable with fitting children with contact lenses from 9-years-old while for parents the average age is 12. Read more
Chinese myopia-lockdown study a portent for Australia
A new phenomenon dubbed “quarantine myopia” is making waves in Australia in the wake of a Chinese study that found myopia prevalence was three times higher in six-year-olds during the COVID-19 pandemic. Read more
Aussies hailed for contribution to global Vision 2020 initiative
Several Australians have been recognised for their contributions to global eye health during the past two decades as part of the International Agency for the Prevention of Blindness (IAPB)’s Vision 2020 agenda. Read more
Roche’s faricimab meets primary endpoint in DME trial
Swiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME) after it produced a similar effect to Eylea in twin clinical trials, but with half the dosing regimen in several patients. Read more
Clinical trial results reinforce potential new treatment for DME
Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to treat diabetic macular edema (DME). Read more
Contact lens that enhances tear flow could prevent dry eye
A grant from CooperVision has supported a team of researchers from the Terasaki Institute for Biomedical Innovation in Los Angeles to develop a contact lens prototype that uses tears to monitor patient health. Read more
Researchers argue sore eyes should replace conjunctivitis as COVID-19 symptom
Sore eyes are the most significant vision-based indicator of COVID-19, according to new research published in the journal BMJ Open Ophthalmology, which calls for a change in the way symptoms are classified. Read more
Screening vital to eliminating COVID transmission risk through donor cornea
Researchers have analysed the prevalence of COVID-19 in human post-mortem ocular tissues, highlighting the importance of the donor screening process. Read more